Isaacs, JD; Boenink, M
(2020)
Biomarkers for dementia: too soon for routine clinical use.
Lancet Neurol, 19 (11).
pp. 884-885.
ISSN 1474-4465
https://doi.org/10.1016/S1474-4422(20)30365-3
SGUL Authors: Isaacs, Jeremy
![[img]](https://openaccess.sgul.ac.uk/style/images/fileicons/application_vnd.openxmlformats-officedocument.wordprocessingml.document.png) |
Microsoft Word (.docx)
Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (25kB) |
Official URL: https://doi.org/10.1016/S1474-4422(20)30365-3
| Item Type: | Article |
|---|---|
| Additional Information: | © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Keywords: | Alzheimer Disease, Amyloidosis, Biomarkers, Dementia, Fluorodeoxyglucose F18, Humans, Humans, Dementia, Alzheimer Disease, Amyloidosis, Fluorodeoxyglucose F18, Biomarkers, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery |
| SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
| Journal or Publication Title: | Lancet Neurol |
| ISSN: | 1474-4465 |
| Language: | eng |
| PubMed ID: | 33098787 |
| Web of Science ID: | WOS:000581121200007 |
 |
Go to PubMed abstract |
| URI: | https://openaccess.sgul.ac.uk/id/eprint/116099 |
| Publisher's version: | https://doi.org/10.1016/S1474-4422(20)30365-3 |
Statistics
Item downloaded times since 15 Feb 2024.
Actions (login required)
 |
Edit Item |